Zenas BioPharma, Inc. Common Stock

ZBIONASDAQ • USD
27.92 USD
↘ 0.10 (0.34%)🟢LIVE (AS OF 01:15 PM EST)
🟢Market: OPEN

Zenas BioPharma, Inc. Common Stock (ZBIO) trades at $27.92 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, ZBIO is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 13, 2026.

Open?$27.79
High?$28.42
Low?$27.54
Prev. Close?$28.01
Volume?154.4K
Avg. Volume?523.7K
VWAP?$27.90
Rel. Volume?0.29x
Bid / Ask
Bid?$24.01 × 100
Ask?$28.13 × 100
Spread?$4.12
Midpoint?$26.07
Valuation & Ratios
Market Cap?1.9B
Shares Out?N/A
Float?31.2M
Float %?47.8%
P/E Ratio?N/A
P/B Ratio?7.69
EPS?-$7.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
Employees
167
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-09-13
Address
852 WINTER STREET, SUITE 250
WALTHAM, MA 02451
Phone: 857-271-2954
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
1
Momentum?
50
Short Sent.?
35
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.63Distress
Confidence?53%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?36.44%Squeeze Risk
Short Interest?11.4M
Days to Cover?24.1
Free Float31.2M
Avg Daily Volume471.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?9.93Strong
Quick Ratio?9.93Strong
Cash Ratio?2.99Strong
Debt/Equity?1.20Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
24
7.69FAIR▾
P/S?
Peers
100
S&P
3
1,899.58HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.2CHEAP▾
EV/Sales?
Peers
100
S&P
3
2,000.02HIGH▾
Returns & Efficiency
ROE?
S&P
3
-196.0%WEAK▾
ROA?
S&P
3
-69.0%WEAK▾
Cash Flow & Enterprise
FCF?$-225974000
Enterprise Value?$2.0B
Fundamentals ratios updated end of day